Skip to content

Sodium in Adolescents and adults Lowering Trial: the SALT trial

A randomised controlled trial to assess the efficacy of a low sodium salt substitute enriched with potassium to improve sodium-to-potassium ratio and reduce blood pressure in adolescents and their families in Soweto, South Africa

Status
Recruiting
Phases
Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202306727520808
Enrollment
1500
Registered
2023-06-19
Start date
2023-07-10
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Circulatory System Nutritional, Metabolic, Endocrine

Interventions

Potassium enriched low sodium salt substitute
Usual table salt

Sponsors

MRC Wits Developmental Pathways for Health Research Unit
Lead Sponsor
Wits Health Hubb
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Male/Female. 2. African descent living in Soweto. 3. Adolescents, aged 13-19 years, primary caregiver (parent/guardian) and where the primary caregiver is <40 years of age, also a member of the household (aged 40-70 years). 4. Eats in the home a minimum of five days a week. 5. Stays in the home a minimum of five days a week. 6. Individuals presenting with new clinical hypertension (will be referred). 7. Use of ACE inhibitors or Angiotensin receptor blockers (participant will be flagged for monitoring.

Exclusion criteria

Exclusion criteria: 1. Inability to read or understand English. 2. Self-reported previous diagnosis of kidney disease/diminished kidney function (any household member regardless of participation). 3. Urine dipstick indicating potential kidney disease/diminished kidney function as indicated by proteinurea (any household member regardless of participation). 4. Estimated Glomerular Filtration Rate below 60 mL/min (any household member over 20 years of age regardless of participation). 5. Use of Potassium-sparing diuretics (any household member regardless of participation). 6. Potential contraindication to the potassium-enriched salt (any household member regardless of participation). 7. Considered to eat most meals outside of the home. 8. Previous diagnosis or currently self-reporting any eating disorder. 9. Participating in any other trial. 10. Households without cooking facilities. 11. High-level athletes. 12. Self-reported pregnancy at time of screening (any household member regardless of participation).

Design outcomes

Primary

MeasureTime frame
In adolescents and adults: Difference in change in spot urinary sodium-to-potassium molar ratio from baseline to 16 weeks.;In adults: Difference in change in systolic BP from baseline to 16 weeks.

Secondary

MeasureTime frame
In adolescents: Difference in change in systolic and diastolic BP from baseline to 16 weeks.;In adults: Difference in change in diastolic BP and spot urinary sodium-to-potassium molar ratio from baseline to 16 weeks.

Countries

South Africa

Contacts

Public ContactSimone Crouch

Post Doctoral Fellow

simone.crouch@wits.ac.za+27729950919

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 9, 2026